Skip to content
StockMarketAgent
Sector pending / Surgical and Medical Instruments and ApparatusUpdated 2026-05-10 22:07 UTC

XKON/390110 stock hub

XKON/390110 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

XKON/390110is not in this month’s coverageGet our monthly research letter — no spam
Fair value midpoint
n/a
Fair value pending
Upside to midpoint
n/a
Based on latest report
Confidence
n/a
Data quality and model convergence
Market cap
2.3B
Korea New Exchange
Market data

Live price

Current market quote for this ticker.

Current price
XKON/390110
In the news

Latest news · XKON/390110

Recent company headlines from major financial publishers.

Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming
DateLoading
Window
EPS estimate
Revenue estimate
Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a
P25 n/aP50 n/aP75 n/a
Trailing P/En/a
P25 n/aP50 n/aP75 n/a
ROE-248.6
P25 n/aP50 n/aP75 n/a
ROIC-54.2
P25 n/aP50 n/aP75 n/a
Benchmarks - 1M
S&P 500n/a
Nasdaq Compositen/a
Dow Jones Industrial Averagen/a
Russell 2000n/a
Indicator catalog

All XKON/390110 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields
137
Groups with data
10
Currency
KRW
Showing 137 of 137 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

13
MetricValue
Country
South Korea
Country code
KR
Exchange
Korea New Exchange
Financial currency
KRW
First seen
2026-05-10
Industry
Surgical and Medical Instruments and Apparatus
Last refreshed
2026-05-10
Market cap
KRW 2.3B
Price
KRW 253
Price currency
KRW
Sic
3841
Symbol
xkon/390110
Website
https://anymedi.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

4
MetricValue
Earnings Yield
-481.62%
FCF yield
-325.6%
P/B ratio
0.35x
P/S ratio
6.93x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

8
MetricValue
Gross margin
-94.43%
Gross Profit
KRW -315.7M
Net Income
KRW -11.2B
Pretax Margin
-3,337.3%
ROA
-36.89
ROCE
-80.32
ROE
-248.6
ROIC
-54.2

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

3
MetricValue
Cagr1y
-79.44%
Cagr3y
-66.07%
Revenue Growth
153.78x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

19
MetricValue
Asset Turnover
KRW 0.03
Assets
KRW 11.7B
Cash
KRW 3.1B
Current Assets
KRW 4B
Current Liabilities
KRW 1.9B
Debt
KRW 3.6B
Debt Equity
KRW 0.55
Debt FCF
KRW -0.48
Equity
KRW 6.7B
Interest Coverage
-21.88
Liabilities
KRW 5.1B
Long Term Assets
KRW 7.8B
Long Term Liabilities
KRW 3.1B
Net Cash
KRW -508.1M
Net Cash By Market Cap
KRW -21.93
Net Debt Equity
KRW 0.08
Tangible Book Value
KRW 5.7B
Tangible Book Value Per Share
KRW 1,023
WACC
7.84

Liquidity

Current-asset coverage and working-capital efficiency metrics.

5
MetricValue
Current ratio
2.05
Inventory Turnover
7.98
Net Working Capital
KRW -431.5M
Quick ratio
1.9
Working Capital
KRW 2B

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

35
MetricValue
1Y total return
-79.41%
200-day SMA
1,315.4
3Y total return
-96.1%
50-day SMA
470.4
50-day SMA vs 200-day SMA
50under200
All Time High
12,650
All Time High Change
-97.78%
All Time High Date
2023-01-27
All Time Low
242
All Time Low Change
16.12%
All Time Low Date
2026-05-08
ATR
95.59
Beta
0.67
Beta1y
1.11
Beta2y
0.4
Ch YTD
-83.47
High
300
High52
2,585
High52 Date
2026-01-09
High52ch
-90.21%
Low
242
Low52
242
Low52 Date
2026-05-08
Low52ch
4.55%
Ma50ch
-40.27%
Price vs 200-day SMA
-78.64%
RSI
32.93
RSI Monthly
26.67
RSI Weekly
28.74
Sharpe ratio
-0.62x
Sortino ratio
-0.8
Tr YTD
-83.47
Tr1m
-29.75%
Tr1w
-14.33%
Tr3m
-72.1%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

2
MetricValue
Operating Income
KRW -7.9B
Operating margin
-2,354.1

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

4
MetricValue
Float
2,753,770%
Net Borrowing
-647,831,950
Shares Insiders
37.32%
Shares Out
9,157,047

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

44
MetricValue
Adjusted FCF
KRW -7.6B
Average Volume
3,493.75x
Bv Per Share
1,078.3
CAPEX
KRW -1.2B
Ch1m
-29.75
Ch1w
-14.33
Ch1y
-79.41
Ch3m
-72.1
Ch3y
-96.1
Ch6m
-83.57
Change
-9.96%
Change From Open
4.55
Close
281
Days Gap
-13.88
Depreciation Amortization
982,416,010
Dollar Volume
1,296,625
EBIT
KRW -7.9B
EBITDA
KRW -6.9B
EPS
KRW -1,998
F Score
1
FCF
KRW -7.5B
FCF Per Share
KRW -824
Financing CF
3,273,511,760
Fiscal Year End
December
Founded
2,006
Investing CF
-1,589,957,710
Is Primary Listing
1
Ma150
1,236.3
Ma150ch
-77.27%
Ma20
399.3
Ma20ch
-29.62%
Net CF
-4,656,968,070
Open
242
Position In Range
18.97
Ppne
6,950,545,350
Price Date
2026-05-08
Ptbv Ratio
0.41
Relative Volume
1.47x
Revenue
334,339,640x
SBC By Revenue
7.22x
Share Based Comp
24,132,290
Tr6m
-83.57%
Volume
5,125
Z Score
-4.47
Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate
n/a
Named kill scenarios are reviewed before any bullish rating can stand.
Moat score
n/a
Business quality stays separate from stock attractiveness.
Forward P/E
n/a
Valuation uses the full report model stack, not a single multiple.
Next action
Research pending
Final action steps are kept in the recommendation tab.
Income

Does XKON/390110 pay a dividend?

Capital-return profile for this ticker.

Performance

XKON/390110 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

1Y total return
-79.4%
S&P 500 1Y: n/a
3Y total return
-96.1%
S&P 500 3Y: n/a
5Y total return
n/a
S&P 500 5Y: n/a
10Y total return
n/a
S&P 500 10Y: n/a
Ownership

Who owns XKON/390110?

Insider, institutional, and short-interest positioning.

Institutional ownership
n/a
Share of float held by funds and institutions
Insider ownership
+37.3%
Stake held by company insiders. Higher generally signals alignment.
Short interest
n/a
Float sold short by bearish positioning
Y/Y dilution
n/a
Negative means the company is buying back shares.
Technical

XKON/390110 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)
32.9
Neutral momentum band
Price vs 200-day MA
-78.6%
50/200-day relationship not available
Beta (5Y)
0.67
Less volatile than the market
Sharpe ratio
-0.62
Risk-adjusted return — higher is better; >1.0 is solid.
Questions

About XKON/390110

Hub-level FAQ points readers to the deeper analysis pages.

What is the current xkon/390110 stock rating?

xkon/390110 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full xkon/390110 analysis?

The full report lives at /stocks/xkon/390110/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for xkon/390110?

The latest report frames xkon/390110 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the xkon/390110 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.

xkon/390110 stock profile: metrics, valuation and analysis | Hisse Senedi Piyasası AI Ajanı